Cervical cancer screening programs in Latin America: current recommendations for facing elimination challenges
DOI:
https://doi.org/10.21149/13204Palabras clave:
uterine cervical neoplasms, papillomavirus infections, mass screening, public policy, HIV, Latin AmericaResumen
Objective. To describe current cervical cancer screening program guidelines in Latin America. Materials and methods. We searched official recommendations for the general population and women living with HIV (WLHIV) by reviewing official sources from 19 countries; these data were supplemented with a consultation carried out by the WHO with the Ministries of Health. Results. Screening policies vary significantly in regard to target populations, primary tests, and screening intervals. Sixteen countries have recently updated their recommendations; however, cytology remains the primary screening test for most countries. Eleven countries have introduced HPV tests, and eight countries have implemented screen-and-treat algorithms; only three countries have developed evidence-based guidelines. All countries but Costa Rica have specific recommendations for WLHIV. Conclusions. Although most countries have updated their screening policies, only a few are properly aligned with the WHO elimination strategy. Recommendations for WLHIV require better integration with cervical cancer screening programs.
Descargas
Citas
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49. https://doi.org/10.3322/caac.21660
World Health Organization. Draft: Global Strategy towards the elimination of cervical cancer as a public health program. Geneva: WHO, 2020 [cited 2020 Jun 8]. Available from: https://www.who.int/publications/m/item/draft-global-strategy-towards-eliminating-cervical-cancer-as-a-public-health-problem
Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395(10224):575-90. https://doi.org/10.1016/S0140-6736(20)30068-4
International Agency for Research on Cancer. Global Cancer Observatory. Lyon: International Agency for Research on Cancer, 2020 [cited 2021 Jan 29]. Available from: https://gco.iarc.fr/
Almonte M, Murillo R, Sánchez GI, González P, Ferrera A, Picconi MA, et al. Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: the ESTAMPA screening study protocol. BMJ Open. 2020;10(5):e035796. https://doi.org/10.1136/bmjopen-2019-035796
Murillo R, Herrero R, Sierra MS, Forman D. Cervical cancer in Central and South America: Burden of disease and status of disease control. Cancer Epidemiol. 2016;44(1):S121-30. https://doi.org/10.1016/j.canep.2016.07.015
World Health Organization, Pan American Health Organization. Cancer country profiles. OMS, PAHO, 2020 [cited 2022 Jan 12]. Available from: https://www3.paho.org/hq/index.php?option=com_docman&view=list&slug=4-cancer-country-profiles-2020&Itemid=270&lang=es
World Health Organization. Comprehensive Cervical Cancer Control. A guide to essential practice. Geneva: WHO, 2014 [cited 2020 Sep 3]. Available from: https://www.who.int/reproductivehealth/publications/cancers/cervical-cancer-guide/en/
de Sanjose S, Holme F. What is needed now for successful scale-up of screening?Papillomavirus Res. 2019;7:173-5. https://doi.org/10.1016/j.pvr.2019.04.011
Pan American Health Organization. Plan of action for cervical cancer prevention and control 2018-2030. Washington DC: PAHO, 2018 [cited 2020 Jun 8]. Available from: https://www.paho.org/hq/index.php?option=com_docman&view=download&category_slug=mandates-strategies-3448&alias=47584-plan-cervical-cancer-2018-2030&Itemid=270&lang=en
Lynge E, Törnberg S, von Karsa L, Segnan N, van Delden JJM. Determinants of successful implementation of population-based cancer screening programmes. Eur J Cancer. 2012;48(5):743-8. https://doi.org/10.1016/j.ejca.2011.06.051
Murillo R. Social inequalities in cancer in Latin America. In: Vaccarella S, Lortet-Tieulent J, Saracci R, Conway DI, Straif K, Wild CP, editors. Reducing social inequalities in cancer: Evidence and priorities for research. Lyon: IARC Scientific Publication, 2019:223-6 [cited 2020 Jun 8]. Available from: https://publications.iarc.fr/Book-And-Report-Series/Iarc-Scientific-Publications/Reducing-Social-Inequalities-In-Cancer-Evidence-And-Priorities-For-Research-2019
Instituto Nacional de Câncer, Ministério da Saúde. Diretrizes Brasileiras para o Rastreamento do Câncer do Colo do Útero. Rio de Janeiro: Inca, 2016 [cited 2020 Jun 8]. Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//diretrizesparaorastreamentodocancerdocolodoutero_2016_corrigido.pdf
Ministerio de Salud. Guías Clínicas AUGE, Cáncer Cérvico Uterino. Santiago: Minsal, 2015 [cited 2020 Jun 8]. Available from: https://www.minsal.cl/wp-content/uploads/2015/09/GPC-CaCU.pdf
Ministerio de Salud y Protección Social. Guía de Práctica Clínica para la detección y manejo de lesiones precancerosas de cuello uterino. Colombia: Ministerio de Salud y Protección Social, 2014 [cited 2022 Jan 12]. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/CA/gpc-lesiones-precancerosas-cuello-uterino-padres.pdf
Secretaría de Salud. Programa de Acción Específico 2007-2012. Cáncer cervicouterino. Mexico City: Secretaría de Salud, 2008 [cited 2020 Jun 8]. Available from: http://www.cnegsr.salud.gob.mx/contenidos/descargas/CaCu/pae_cacu.pdf
Secretaría de Salud. Programa de acción específico, prevención y control del cáncer de la mujer 2013-2018. Mexico City: Secretaría de Salud, 2014 [cited 2020 Jun 8]. Available from: https://www.gob.mx/cms/uploads/attachment/file/10046/PrevencionyControldelCancerdelaMujer_2013_2018.pdf
Ministerio de Salud, Coordinación Nacional de Salud Sexual y Reproductiva. Normas de prevención, detección y seguimiento de las lesiones preinvasoras del cuello uterino y guías de manejo. Panamá: Ministerio de Salud, 2017 [cited 2020 Jun 8]. Available from: http://www.minsa.gob.pa/sites/default/files/programas/normas_de_prevencion_cacu.pdf
Arrossi S, Thouyaret L, Paul L. Prevención del cáncer cervicouterino. Recomendaciones para el tamizaje, seguimiento y tratamiento de mujeres en el marco de programas de tamizaje basados en el test de VPH: actualización. Buenos Aires: Instituto Nacional del Cáncer Argentina, 2015 [cited 2020 Jun 8]. Available from: https://bancos.salud.gob.ar/sites/default/files/2018-10/0000000017cnt-manual_recomendaciones_tamizaje_2015_baja.pdf
Secretaría de Salud. Protocolo para el tamizaje y tratamiento de lesiones premalignas para la prevención del cáncer cervicouterino. Honduras: Secretaría de Salud, 2015 [cited 2022 Jan 12]. Available from: https://ex-tranet.who.int/ncdccs/Data/HND_D1_Protocolo%20C%C3%A1ncer%20C%C3%A9rvicouterino%20(30%20NOV).pdf
Ministerio de Salud Pública y Asistencia Social. Guía de atención integral para la prevención, detección y tratamiento de lesiones precursoras del cáncer cérvico uterino. Guatemala: Ministerio de Salud Pública y Asistencia Social, 2020 [cited 2021 Feb 17]. Available from: https://osarguatemala.org/guia-de-atencion-integral-para-la-prevencion-deteccion-y-tratamiento-de-lesiones-precursoras-del-cancer-cervico-uterino/
Fernández-Deaza G, Caicedo-Martínez M, Serrano B, Roura E, Castillo JS, Silvia de S, et al. Appendix A and B. Figshare 2022. Available from: https://doi.org/10.6084/m9.figshare.20235681.v1
World Health Organization, International Agency for Research on Cancer, Working Group on the Evaluation of Cancer Preventive Agents. Cervix cancer screening. IARC Handbooks of Cancer Prevention. Lyon: IARC Press, 2005 [cited 2020 Jun 8]. Available from: https://publications.iarc.fr/Book-And-Report-Series/Iarc-Handbooks-Of-Cancer-Prevention/Cervix-Cancer-Screening-2005
Koliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PP, Mustafa RA, et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst Rev. 2017;8(8):CD008587. https://doi.org/10.1002/14651858.CD008587.pub2
Chrysostomou A, Stylianou D, Constantinidou A, Kostrikis L. Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing. Viruses. 2018;10(12):729. https://doi.org/10.3390/v10120729
US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, et al. Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(7):674-86. https://doi.org/10.1001/jama.2018.10897
Canadian Task Force on Preventive Health Care. Recommendations on screening for cervical cancer. CMAJ. 2013;185(1):35-45. https://doi.org/10.1503/cmaj.121505
Arbyn M, Smith SB, Temin S, Sultana F, Castle P. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ. 2018;363:k4823. https://doi.org/10.1136/bmj.k4823
Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmerón J, Uribe P, Velasco-Mondragón E, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet. 2011;378(9806):1868-73. https://doi.org/10.1016/S0140-6736(11)61522-5
Arrossi S, Thouyaret L, Herrero R, Campanera A, Magdaleno A, Cuberli M, et al. Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial. Lancet Glob Health. 2015;3(2):e85-94. https://doi.org/10.1016/S2214-109X(14)70354-7
Holme F, Jerónimo J, Maldonado F, Camel C, Sandoval M, Martínez- Granera B, et al. Introduction of HPV testing for cervical cancer screening in Central America: The Scale-Up project. Prev Med. 2020;135:106076. https://doi.org/10.1016/j.ypmed.2020.106076
Frenk J, Gómez-Dantés O. Health Systems in Latin America: The Search for Universal Health Coverage. Arch Med Res. 2018;49(2):79-83. https://doi.org/10.1016/j.arcmed.2018.06.002
Joint United Nations Programme on HIV/AIDS. Seazing the Moment; tackling entrenched inequalities to end epidemics. Geneva: UNAIDS, 2020 [cited 2020 Oct 5]. Available from: https://www.unaids.org/sites/default/files/media_asset/2020_global-aids-report_en.pdf
Joint United Nations Programme on HIV/AIDS. HIV estimates with uncertainty bounds from 1990-present. Geneva: UNAIDS, 2021 [cited 2022 Jan 12]. Available from: https://www.unaids.org/en/resources/docu-ments/2021/HIV_estimates_with_uncertainty_bounds_1990-present
Mohammed D, Shukla P, Babayants Y, Sison R, Slim J. Increased proportions of HIV-infected women met cervical cancer screening guideline in 2016. Int J Womens Health. 2018;10:83-7. https://doi.org/10.2147/IJWH.S153003
Abraham AG, D’Souza G, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, et al. Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. Acquir Immune Defic Syndr. 2013;62(4):405-13. https://doi.org/10.1097/QAI.0b013e31828177d7
World Health Organization. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva: WHO, 2013 [cited 2020 Oct 5]. Available from: https://apps.who.int/iris/bitstream/handle/10665/94830/9789241548694_eng.pdf
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2022 Salud Pública de México
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Al proponer un trabajo para su publicación, los autores aceptan las condiciones contenidas en las presentes normas y ceden a Salud Pública de México los derechos patrimoniales sobre el artículo en cuestión, a fin de que ésta lo edite, publique, reproduzca, difunda, comercialice, traduzca o autorice su traducción a cualquier idioma.
Los derechos transferidos incluyen la publicación del artículo por cualquier medio, sea éste impreso, magnético o electrónico, o por cualquier otro soporte o medio de difusión que exista o pueda crearse en el futuro, así como la realización de publicaciones mediante la concesión de licencias totales o parciales a terceros.
Los artículos aceptados serán publicados en Salud Pública de México bajo una licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional.
Los trabajos propuestos deberán ser originales e inéditos, y no podrán presentarse a ninguna otra revista mientras se encuentren sometidos a la consideración de Salud Pública de México.También se reciben trabajos completos publicados previamente en forma de resumen, o trabajos no publicados presentados en congresos o seminarios.
Todos los trabajos serán publicados con pleno conocimiento de los autores.
Los artículos firmados son responsabilidad de los autores y no necesariamente reflejan la opinión de la revista, del Instituto Nacional de Salud Pública o de la institución a la que están afiliados los autores.